| Author/year | Controls | Tests | |||||||
|---|---|---|---|---|---|---|---|---|---|
| number | age | errors | number | age | errors | Diff.? | Task/Exp | ||
ADHD | |||||||||
| Rothlind/91 | 20 | 10 | 30 | 21 | 11 | 40 | no | antigap | |
Affective disorders | |||||||||
| Fukushima/90a | 36 | 18-42 | 2±4 | 13 | 14-38 | 4±4 | no | anti | |
Alzheimer | |||||||||
| Currie/91 | 332 | 15-89 | 9±7 | 30 | 49-89 | 10-100 | yes | Fingert. | |
| Fletcher/86 | 6 | 57-76 | 74 | anti | |||||
Cocaine | |||||||||
| Rosse/94 | 32 | 38±12 | 31±13 | 15 | 34±2 | 32±9 | no | anti | |
HIV | |||||||||
| Johnston/96 | 9 | 34±6 | 18 | 12 | 39±8 | 67 | yes | anti | |
| Merril/91 | 25 | 22-48 | 4 | 47 | 22-61 | 70 | yes | antigap | |
Huntington | |||||||||
| Currie/91 | 332 | 18-89 | 9±7 | 5 | 18-64 | 40 | yes | Fingert. | |
| Lasker/87 | 22 | 13-69 | 17±10 | 20 | 17-65 | 60±20 | yes | anti | |
Genetic marker for Huntington | |||||||||
| Rothlind/93 | 56 | 20-43 | 29±14 | 20 | 20-43 | 30±21 | no | anti | |
Lateral Sclerosis | |||||||||
| Shaunak/95 | 11 | 27-69 | 10±10 | 17 | 28-69 | 32 | yes | antigap 0 | |
Obsessive compulsive disorder | |||||||||
| Tien/92 | 14 | 22-56 | 11 | 11 | 27-54 | 39 | yes | anti | |
Pseudodementia | |||||||||
| Currie/91 | 332 | 18-89 | 9±7 | 12 | 35-84 | ? | no | Fingert. | |
Progressive supranuclear palsy | |||||||||
| Pierrot-D/89 | 40 | 64±10 | 15±3 | 40 | 51-80 | 59 | yes | antigap | |
| Vidailhet/94 | 12 | 64±8 | 11 | 10 | 63±5 | 65-82 | yes | antigap | |
Progressive supranuclear palsy: Placebo versus Physostigmine (Acetlycholinesterase inhibitor) | |||||||||
| Blin/95 | 6 | 68-74 | 88±5 | 6 | 68-74 | 75±8 | yes | anti | |
Parkinson | |||||||||
| Kitagawa/94 | 20 | 57±9 | 15±11 | 32 | 45-70 | 28±19 | yes | antigap | |
| Lueck/90 10 | 64-84 | 31±13 | 10 | 54-72 | 39±12 | no | anti | ||
| Vidailhet/94 | 12 | 64±8 | 11 | 14 | 62±7 | 13 | no | anti | |
| Fukushima/94 | 20 | 45-72 | 15±11 | 22 | 40-70 | 25±9 | no | anti | |
Schizophrenia | |||||||||
| Clementz/94 | 27 | 35±14 | 22±16 | 30 | 35±10 | 58±22 | yes | anti | |
| Rosse/93 12 | 38±12 | 29±13 | 27 | 39±7 | 39±9 | yes | antigap | ||
| Fukushima/88 | 10 | 20-39 | 0 | 12 | 19-41 | 0-60 | yes | anti | |
| Fukushima/90a | 36 | 18-42 | 2±3 | 32 | 17-41 | 29±22 | yes | anti | |
| Fukushima/90b | 24 | 18-42 | 4±2 | 24 | 17-41 | 26±22 | yes | anti | |
| Fukushima/94 | 9 | 19-39 | 4±5 | 18 | 16-43 | 34±21 | yes | anti | |
| Matsue/94 | 10 | 25-49 | 3±5 | 20 | 23-46 | ?? | yes | express | |
| Sereno/95 | 14 | 32 | 6 | 17 | 33 | 24 | yes | antigap | |
| Thaker/89 | 8 | 25-35 | 10±8 | 18 | 27-48 | 60±25 | yes | anti | |
| Thaker/89 | 8 | 25-35 | 10±8 | 16 | 21-43 | 35±21 | yes | anti | |
Schizophrenia patients first degree relatives | |||||||||
| Clementz/94 | 27 | 35±14 | 22±16 | 32 | 49±17 | 32±23 | yes | anti | |
Schizophrenia spectrum personality diagnoses | |||||||||
| Thaker/96 | 51 | 29±7 | 24±22 | 32 | 30±8 | 24±13 | no | anti | |
Lesions | |||||||||
| Fukushima/94 | 20 | 45-72 | 15±11 | 10 | 26-72 | 41±32 | yes | anti | frontal,left |
| Gaymard/90 | 20 | 44±16 | 13 | 2 | 34;48 | 5;6 | no | antigap | sup m area |
| Guitton/85 | 9 | y. adult | 20±5 | 26 | y. adult | 59±9 | yes | antigap | frontal, left |
| Guitton/85 | 9 | y. adult | 20±5 | 7 | y. adult | 19±5 | no | antigap | temp., left |
| Pierrot-D/91 | 20 | 70±9 | 13 | 1 | 70 | 51 | yes | antigap | sup coll |
| Pierrot-D/91 | 20 | 59±9 | 13 | 16 | 58±14 | 59-81 | yes | antigap | PFC |
| Pierrot-D/91 | 20 | 59±9 | 13 | 10 | 58±14 | 7-31 | no | antigap | FEF |
| Pierrot-D/91 | 20 | 59±9 | 13 | 10 | 58±14 | 17-34 | no | antigap | PPC |
| Pierrot-D/91 | 20 | 59±9 | 13 | 9 | 58±14 | 4-16 | no | antigap | SMA |
| Rivaud/94 | 12 | 52±13 | 6±33 | 3 | 55±13 | 14 | no | antigap | FEF, left |
| Vidailhet/94 | 12 | 64±8 | 11 | 10 | 65±6 | 22-52 | yes | antigap | Cort-Basal |
| Vidailhet/94 | 12 | 64±8 | 11 | 14 | 62±9 | 7-14 | no | antigap | Stria-ngr |
| Vermesch/96 | 12 | 47±10 | 11 | 9 | 44±11 | 15 | no | antigap | putamen/pallidum |